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Abstract

The catalytic mechanism of the MgATP-dependent carboxylation of biotin in the biotin carboxylase domain of
pyruvate carboxylase from R. etli (RePC) is common to the biotin-dependent carboxylases. The current sitedirected mutagenesis study has clarified the catalytic functions of several residues proposed to be pivotal in
MgATP-binding and cleavage (Glu218 and Lys245), HCO3– deprotonation (Glu305 and Arg301), and biotin
enolization (Arg353). The E218A mutant was inactive for any reaction involving the BC domain and the E218Q
mutant exhibited a 75-fold decrease in 𝑘𝑘cat for both pyruvate carboxylation and the full reverse reaction. The
E305A mutant also showed a 75- and 80-fold decrease in 𝑘𝑘cat for both pyruvate carboxylation and the full
reverse reaction, respectively. While Glu305 appears to be the active site base which deprotonates HCO3–,
Lys245, Glu218, and Arg301 are proposed to contribute to catalysis through substrate binding interactions. The
reactions of the biotin carboxylase and carboxyl transferase domains were uncoupled in the R353M-catalyzed
reactions, indicating that Arg353 may not only facilitate the formation of the biotin enolate but also assist in
coordinating catalysis between the two spatially distinct active sites. The 2.5- and 4-fold increase in 𝑘𝑘cat for the
full reverse reaction with the R353K and R353M mutants, respectively, suggests that mutation of Arg353 allows
carboxybiotin increased access to the biotin carboxylase domain active site. The proposed chemical mechanism
is initiated by the deprotonation of HCO3– by Glu305 and concurrent nucleophilic attack on the γ-phosphate of
MgATP. The trianionic carboxyphosphate intermediate formed reversibly decomposes in the active site to
CO2 and PO43–. PO43– then acts as the base to deprotonate the tethered biotin at the N1-position. Stabilized by
interactions between the ureido oxygen and Arg353, the biotin-enolate reacts with CO2 to give carboxybiotin.
The formation of a distinct salt bridge between Arg353 and Glu248 is proposed to aid in partially precluding
carboxybiotin from reentering the biotin carboxylase active site, thus preventing its premature decarboxylation
prior to the binding of a carboxyl acceptor in the carboxyl transferase domain.

All residues are numbered according to their position in R. etli pyruvate carboxylase, including those mutations
in E. coli biotin carboxylase.
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The biotin-dependent carboxylases, including acetyl-CoA carboxylase, propionyl-CoA carboxylase,
methylcrotonyl-CoA carboxylase, and pyruvate carboxylase (PCa; E.C 6.4.1.1), are essential regulatory enzymes
associated with various metabolic pathways.(1) The MgATP-dependent carboxylation of pyruvate catalyzed by
PC replenishes the oxaloacetate used in gluconeogenesis as well as amino acid and fatty acid synthesis,
highlighting the central importance of PC to intermediary metabolism.(2) The overall reaction catalyzed by PC
occurs in two steps at spatially distinct active sites (Scheme 1). Biotin is initially carboxylated in the biotin
carboxylase (BC) domain by HCO3– (1). Carboxybiotin is subsequently transferred to the carboxyl transferase (CT)
domain on a neighboring polypeptide chain,(3) where pyruvate carboxylation occurs (2).(4) The biotin carboxyl
carrier protein (BCCP) domain carries the biotin cofactor, which is covalently attached to Lys1119, between the
BC and CT domains. While Mg2+ is required as an essential activator for the overall carboxylation reaction, the
necessity of acetyl-CoA as an allosteric activator is highly dependent on the organism from which the enzyme
originates.(5)The BC domain active sites of the biotin-dependent carboxylases share significant sequence and
structural homology,(6) suggesting that the catalytic mechanism of biotin carboxylation may be common to all
members of the family. The three individual functional domains of α4 pyruvate carboxylases, including PC
from R. etli (RePC), are arranged on a single polypeptide chain, offering a unique opportunity to determine the
effects of mutations incorporated in the BC domain on the overall forward and reverse reactions, as well as on
the reactions of the individual BC and CT domains.(3, 7)

Scheme 1. Overall Pyruvate Carboxylation Reaction Catalyzed by RePC Occurs in Two Distinct Steps with the
MgATP-Dependent Biotin Carboxylation Occurring in the BC Domain (1) and the Carboxyl Transfer to Pyruvate
Occurring in the CT Domain (2)
The crystallographic structure of the RePC holoenzyme with ATP-γ-S bound in the active site of the BC domain
revealed those residues likely to be involved in the binding and orientation of MgATP(3) and subsequent crystal
structures of biotin carboxylase from E. coli (EcBC), complexed with free biotin and HCO3–, allowed for the
identification of possible catalytic residues in the putative bicarbonate/biotin pocket (Figure 1).(8)In the
accompanying manuscript, the 2.4 Å resolution description of the structure of the T882A RePC mutant,
cocrystallized with MgADP, acetyl-CoA, and an inhibitory analogue of the carboxyphosphate intermediate,
phosphonoacetate, discloses both the relative positioning and orientation of the covalently attached biotin
cofactor and the probable location of carboxyphosphate in the BC domain active site(9)

Figure 1. Stereo view of the biotin carboxylase active site of wild-type R. etli PC (yellow, pdb 2QF7) complexed
with Mg2+ and ATP-γ-S and E. coli biotin carboxylase (blue, pdb 3G8C) containing HCO3–, MgADP, and free biotin
in the active site. Residues are numbered according to the R. etli sequence, and all figures were generated using
PyMol.(14)
These structural descriptions of the BC domain active site in both RePC and EcBC have revealed the full
complement of highly conserved residues proposed to have prominent catalytic functions in the mechanism of
biotin carboxylation. The current work is a structure-driven, site-directed mutagenesis study of those selected
residues in the BC domain of R. etli PC which are thought to be responsible for MgATP-cleavage (Glu218 and
Lys245), HCO3– deprotonation (Glu305 and Arg301), and biotin enolization (Arg353). The wild-type and mutant
forms of RePC were characterized with respect to their catalytic activities for the full forward and reverse
reactions and the partial reactions of the individual domains. The kinetic data presented here permit the
development of a more definitive description of the catalytic mechanism for the MgATP-dependent
carboxylation of biotin. Additionally, in conjunction with the newly solved structure, described in the preceding
report,(9) of the T882A RePC mutant containing tethered biotin in the BC domain active site, this investigation
revealed a possible mechanism by which the enzyme precludes carboxybiotin re-entry into the BC domain active
site, thus aiding in preventing the decarboxylation of carboxybiotin prior to the coordination of a carboxyl
acceptor in the CT domain. Structural data confirm the presence of a unique salt bridge, possibly formed in the
presence of MgADP, at the entrance of the BC domain active site which may regulate the accessibility of
carboxybiotin to the BC domain active site.

Materials and Methods
Materials

IPTG, biotin, NADP, NADH, ampicillin, and chloramphenicol were purchased from Research Products
International Corp. (RPI). Ni2+-Profinity IMAC resin was obtained from Bio-Rad. The Pierce BCA Assay kit was
purchased from Thermo Scientific, and the EnzChek Phosphate Assay kit was purchased from Invitrogen. All
other materials were obtained from Sigma-Aldrich and of the highest purity available.

Construction of RePC BC Domain Mutants

E305A, E305Q, E305D, E218Q, E218A, K245Q, R301Q, R301K, R353M,and R353K mutants were generated by
site-directed mutagenesis as described previously(7, 10) using oligonucleotides designed to incorporate the
above substitutions (Table S1). Mutagenic reactions were performed on a 1.8 kb SacII-XhoI fragment encoding
the BC domain of RePC gene, and the nucleotide sequences of the mutants were determined by automatic
sequencing. The equivalent fragment of the wild-type RePC gene in the expression clone was then replaced with
the mutagenic cassette. The E305A/K1119Q and R353M/K1119Q double mutants were generated using the
K1119Q plasmid as a template and the primers in Table S1.

Overexpression and Purification of Protein

Preparation and purification of the wild-type and mutant forms of RePC were essentially performed as
previously described.(7) The wild-type and mutant RePC proteins were purified using Ni2+-affinity

chromatography, concentrated to approximately 2–5 mg/mL, and used without further purification or
manipulation. Total protein concentrations were quantified with the Pierce BCA colorimetric assay (Thermo
Scientific). The nearly complete (>98%) biotinylation of wild-type and RePC mutant proteins that did not contain
a mutation at Lys1119 was confirmed via SDS-PAGE analysis of an avidin binding gel-shift assay.(7)

Sedimentation Analysis of the Quaternary Structure of the E218Q RePC Mutant
Sedimentation velocity analytical centrifugation was performed with a Beckman ProteomeLab XL-A
ultracentrifuge using the absorbance optics system to visualize the protein at a wavelength of 280 nm. Twosector cells were used, and data were acquired every 0.003 cm. Data were collected as 300 absorbance scans
with a nominal time increment of 1 min at 30 °C and at a speed of 40K rpm. Enzyme samples were prepared at
the concentration of 2 μM in 0.1 M Tris-HCl (pH 7.8), 20 mM NaHCO3, 5 mM MgCl2, 10 mM pyruvate, 0.1 mM
acetyl CoA, and 1 mM DTE. The computer-captured data were analyzed with SEDFIT.(11) The partial specific
volumes of the enzymes were calculated from the amino acid composition using SEDNTERP
[www.bbri.org/RASMB].(11) The density of the Tris-HCl buffer (1.005 g/mL) was assumed to be the density of
the enzyme solution. The raw sedimentation and ultracentrifugation data are presented in the Supporting
Information (Table S2 and Figure S1).

Enzymatic Assays
The coupled assay systems used to monitor the full forward and reverse reactions and the partial forward and
reverse reactions of the individual domains are shown in Table 1. A mixed-buffer system (50 mM Bis-Tris, 25 mM
tricine, and 25 mM glycine; pH 7.5) was determined to have no effect on the activities of RePC and was used for
all the enzymatic assays. The methods and specific reaction conditions for the coupled assay systems used in the
current study are similar to those previously described(7) and further detailed in the Supporting Information.
Table 1. Enzymatic Reactions and Assaysa

Products highlighted are those assayed to determine specific activities and initial rates.
Detailed reaction and assay conditions are described in the Supporting Information.
Table c
Domains involved in the reaction, BC = biotin carboxylase, CT = carboxyl transferase.
Table d
PNP/MESG = purine nucleoside phosphorylase and 2-amino-6-mercapto-7-methylpurine riboside.
Table a

Table b

Determination of the Extent of Coupling between the Rates of Pi Release and
Oxaloacetate Formation
The initial rates of oxaloacetate formation and Pi release were determined at varying concentrations of pyruvate
(0.09–5.25 mM) in order to determine the degree of coupling between the two reactions. For the determination
of the rate of Pi release in these experiments, the EnzChek Phosphate (Invitrogen) assay system was used. The
PNP-catalyzed phosphorylation of MESG to ribose-1-phosphate and 2-amino-6-mercapto-7-methyl purine with
Pi was used as an effective coupled assay system to measure the initial rate of Pi release(12) during the RePCcatalyzed HCO3–-dependent ATPase reaction. Initial rates were determined by monitoring the corresponding
increase in absorbance at 360 nm due to the formation of 2-amino-6-mercapto-7-methylpurine. Under the
conditions used for the HCO3–-dependent ATPase reaction (50 mM Bis-Tris, 25 mM tricine, 25 mM glycine, pH
7.5, 25 °C), the extinction coefficient for the purine product was determined to be 6300 cm–1 M–1 and used for all
subsequent calculations. To ensure that the initial rates of the two reactions were determined under nearly
identical conditions, two 1 mL reactions containing 50 mM Bis-Tris, 25 mM tricine, 25 mM glycine (pH 7.5), 15
mM HCO3–, 5.0 mM MgCl2, 2.5 mM MgATP, and 0.25 mM acetyl-CoA were prepared at each concentration of
pyruvate (0.09–5.25 mM). For the determination of oxaloacetate formation, 0.24 mM NADH and malate
dehydrogenase (10 U) were added and the reduction of NADH to NAD+ was determined at 340 nm. 3 U of PNP
and 0.2 mM of MESG were added to the reaction mixtures where the initial rates of Pi release were being

determined and the background rate of MESG decomposition was monitored for ∼2 min at 360 nm. Reactions
were then initiated with the addition of RePC, and the corrected rate was used to determine the initial rate of
Pi release. Data for the wild-type-catalyzed reactions and the ratios of the initial rates of oxaloacetate
formation/initial rates of Pi release at varying pyruvate concentrations were fitted to eq 1. Ratios of the initial
rate of oxaloacetate formation to Pi release for the R353M-catalyzed reactions were fitted to eq 4. For the
E305A mutant-catalyzed reaction, data were fitted to eq 1. Standard errors reported for all kinetic parameters
were determined from the fits of these data to the corresponding equation.

Data Analysis

𝑘𝑘cat (min–1) and 𝑘𝑘cat /𝐾𝐾m (min–1 mM–1) values were determined by fitting velocity versus substrate concentration
data to eq 1 using least-squares nonlinear regression, where A is the substrate concentration. All least-squares
fits were performed using FORTRAN programs,(13) and best-fit lines were plotted using SigmaPlot v. 12.0.

𝑣𝑣 =

(1)

𝑉𝑉max 𝐴𝐴
𝑘𝑘a + 𝐴𝐴

Substrate inhibition data were fitted to eq 2, where A is the concentration of substrate and Ki is the inhibition
constant for the substrate.

(2)

𝑣𝑣 =

𝑉𝑉max 𝐴𝐴

𝐾𝐾a + 𝐴𝐴 �1 +

𝐴𝐴
�
𝐾𝐾i

Inhibition data for the R353M/K1119Q catalyzed HCO3–-dependent ATPase reaction by free biotin were fitted to
eq 3, where A is the concentration of MgATP, I is the concentration of free biotin, and 𝐾𝐾i is the inhibition
constant for biotin.

(3)

𝑣𝑣 =

𝑉𝑉max 𝐴𝐴

𝐾𝐾a + 𝐴𝐴 �1 +

𝐼𝐼
�
𝐾𝐾i

To determine the extent of coupling between MgATP-cleavage and oxaloacetate formation, the ratios of the
initial rate of oxaloacetate formation to Pi release in the R353M catalyzed reactions at varying concentrations of
pyruvate were fitted to a two/one function (eq 4)

(4)

initial rates of oxaloacetate formation 𝑉𝑉 (𝐴𝐴2 + 𝑑𝑑𝑑𝑑)
= 2
initial rates of Pi release
𝐴𝐴 + 𝑏𝑏𝑏𝑏 + 𝑐𝑐

where A is the concentration of pyruvate, V is the limiting ratio of oxaloacetate formation to Pi release at
saturating concentrations of pyruvate, and b, c, and d are kinetic constants associated with the extent of
coupling between oxaloacetate formation and Pi release at varying pyruvate concentrations.

Results
Reactions Involving the Carboxyl Transferase Domain
The 𝑘𝑘cat (min–1) and 𝑘𝑘cat /𝐾𝐾m,MgATP (min–1 mM–1) for pyruvate carboxylation were determined by measuring the
initial rates of oxaloacetate formation for the RePC mutant-catalyzed reactions (Table 2). Most mutations of the
proposed catalytic residues in the BC domain had pronounced effects on both the rate and catalytic efficiency
for pyruvate carboxylation. Of those enzymes which retained pyruvate carboxylation activity, the R301K and
R353K mutant RePCs exhibited the greatest decrease in 𝑘𝑘cat as compared to the wild-type rate (180- and 160fold reduction, respectively). Unlike the conservative E305D mutation, which had a relatively small effect
on 𝑘𝑘cat only, the mutation of Glu305 to Ala resulted in a 75-fold decrease in 𝑘𝑘cat and almost 30-fold decrease
in 𝑘𝑘cat /𝐾𝐾m,MgATP . The sizable increases in the 𝐾𝐾m for MgATP resulted in an 1850-fold decrease in 𝑘𝑘cat /𝐾𝐾m for
the R301K mutant and a 170-fold decrease for the K245Q mutant. Interestingly, the E218Q, R353M, and R301Q
mutant forms of RePC showed noticeable MgATP substrate inhibition of the full forward reaction. The
apparent 𝐾𝐾m (0.03 mM) and 𝐾𝐾i (1.5 mM)values for MgATP determined for each of the three mutant-catalyzed
reactions were virtually identical within experimental error. While the E218Q mutant retained a small amount of
pyruvate carboxylating ability, the E218A mutant RePC enzyme lacked catalytic activity for both pyruvate
carboxylation and the full reverse reaction. Although decreased activities and catalytic efficiencies were
observed in the E305A and R353M-catalyzed reactions, pyruvate carboxylation activity was not observed with
the E305A/K1119Q and R353M/K1119Q double mutants.

Table 2. Activities of the Biotin Carboxylase Domain Mutants for the Pyruvate Carboxylation Reactiona
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 (min–1)b % wild-type rate 𝑲𝑲𝐦𝐦,𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌 (mM) 𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /𝑲𝑲𝐦𝐦,𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌 (min–1 mM–1) % wild-type 𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /𝑲𝑲𝐦𝐦,𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌
wild-type
700 ± 80
(100)
0.27 ± 0.04
2590 ± 15
(100)
c
E218A
NA
E218Q
8.0 ± 0.3
1.1
0.03 ± 0.005d
270 ± 10
10
K245Q
71 ± 4
10
4.82 ± 0.07
15 ± 1
0.6
E305A
9.2 ± 0.2
1.3
0.09 ± 0.01
96 ± 12
4
E305Q
87 ± 1
12
1.32 ± 0.06
64 ± 1
2.5
E305D
187 ± 1
27
0.32 ± 0.08
580 ± 20
22
R301Q
18 ± 1
2.5
0.05 ± 0.02e
340 ± 10
13
R301K
3.8 ± 0.4
0.5
2.8 ± 0.2
1.4 ± 0.9
0.05
R353K
4.3 ± 0.1
0.6
0.12 ± 0.01
35 ± 4
1.4
f
R353M
28 ± 1
4
0.034 ± 0.009
760 ± 10
30
E305A/K1119Q NA
R353M/K1119Q NA
a
Reaction conditions: 50 mM Bis-Tris, 25 mM tricine, 25 mM glycine (pH 7.5), 25 °C, 25 mM HCO3–, 12 mM pyruvate, 7.0 mM MgCl2, MgATP (0.075–3.0
mM), 0.25 mM acetyl-CoA.
b
Data fitted to eq 1 unless otherwise indicated.
c
NA = no activity detected.
d
Substrate inhibition with respect to MgATP data fitted to eq 2, Ki = 1.1 ± 0.2 mM.
e
Substrate inhibition, 𝐾𝐾i = 1.2 ± 0.3 mM.
f
Substrate inhibition, 𝐾𝐾i = 1.8 ± 0.2 mM.

The effects of the BC domain mutations on the specific activities for the full reverse reaction (Table 3) were
similar to those on the full forward reaction. A 75-fold decrease in 𝑘𝑘cat for both the full forward and full reverse
reactions were observed with the E305A RePC mutant whereas the effects of the R301K (7-fold decrease),
E218Q (10-fold decrease), and E305Q (22-fold decrease) mutations on the activities of the full reverse reaction
were not as pronounced as those observed for the full forward reaction. Unexpectedly, the specific activities
determined for reactions catalyzed by the R353K and R353M mutants, both of which showed marked decreases
in the 𝑘𝑘cat for pyruvate carboxylation, were 2.5- and 4-fold greater than the rate of the wild-type-catalyzed
reaction, respectively. In order to determine if the observed rate acceleration was due to increased activation by
the allosteric effector, acetyl-CoA, specific activities for the full reverse reaction were determined in the absence
of acetyl-CoA (Table 4). Unlike the wild-type-catalyzed reaction, which showed only 18% activity in the absence
of acetyl-CoA, the presence or absence of acetyl-CoA appeared to have little effect on the specific activities for
the full reverse reaction catalyzed by the R353M and R353K RePC mutants.
Table 3. Specific Activities of the Biotin Carboxylase Domain Mutants for the Full Reverse Reactiona
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 (min–1)b % wild-type rate
wild-type
0.835 ± 0.005 (100)
E218A
NAc
E218Q
0.077 ± 0.001 9
K245Q
0.23 ± 0.03
27
E305A
0.011 ± 0.002 1
E305Q
0.037 ± 0.001 4
E305D
0.42 ± 0.02
50
R301Q
0.45 ± 0.02
50
R301K
0.12 ± 0.01
14
R353K
2.10 ± 0.05
250
R353M
3.28 ± 0.02
390
E305A/K1119Q NA
R353M/K1119Q NA
a
Reaction conditions: 50 mM Bis-Tris, 25 mM tricine, 25 mM glycine (pH 7.5), 25 °C, 7.5 mM MgCl2, 3.0 mM ADP,
2.5 mM phosphate, 0.95 mM oxaloacetate, 0.25 mM acetyl-CoA.
b
Number of determinations = 3, error reported is standard deviations of 3 trials.
c
NA = no activity detected.
Table 4. Specific Activities of the Biotin Carboxylase Domain Mutants for the Full Reverse Reaction in the
Absence of Acetyl-CoAa
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 (min–1)b % of rate with acetyl-CoA
wild-type 0.152 ± 0.003 18
R301Q
0.376 ± 0.004 85
R353K
2.75 ± 0.02
130
R353M
3.09 ± 0.08
94
a
Reaction conditions: 50 mM Bis-Tris, 25 mM tricine, 25 mM glycine (pH 7.5), 25 °C, 7.5 mM MgCl2, 3.0 mM ADP,
2.5 mM phosphate, 0.95 mM oxaloacetate.
b
Number of determinations = 3, error reported is standard deviations of 3 trials.
c
NA = no activity detected.
While the oxamate-induced decarboxylation of oxaloacetate is proposed to occur solely within the confines of
the CT domain,(15) previous studies suggest that mutations in one domain can have an effect on reactions

occurring in the neighboring domain.(7) Mutations in the BC domain appeared to affect the rates of the
oxamate-induced decarboxylation of oxaloacetate to varying degrees (Table 5). Most notable was the 96% and
94% loss in activity, as compared to wild-type, with the E218A and E218Q mutants, respectively. Sedimentation
analysis of the quaternary structure of the E218Q RePC mutant indicates that this mutant exists predominately
as a tetramer in solution (Table S2 and Figure S1).
Table 5. Specific Activities of the Biotin Carboxylase DomainMutants for the Oxamate-Induced
Decarboxylation of Oxaloacetatea
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 (min–1)b % wild-type rate
wild-type
9.03 ± 0.04
(100)
E218A
0.42 ± 0.01
4
E218Q
0.59 ± 0.01
6
K245Q
2.01 ± 0.01
22
E305A
3.28 ± 0.07
36
E305Q
1.27 ± 0.02
14
E305D
7.45 ± 0.05
82
R301Q
6.0 ± 0.1
66
R301K
5.67 ± 0.07
63
R353K
4.23 ± 0.09
47
R353M
5.8 ± 0.2
64
c
E305A/K1119Q NA
R353M/K1119Q NA
a
Reaction conditions: 50 mM Bis-Tris, 25 mM tricine, 25 mM glycine (pH 7.5), 25 °C, 1 mM oxamate, 0.95 mM
oxaloacetate, 0.25 mM acetyl-CoA.
b
Number of determinations = 3, error reported is standard deviations of 3 trials.
c
NA = no activity detected.

Reactions Involving Only the BC Domain

RePC catalyzes the HCO3–-dependent ATPase reaction in the absence of carboxyl acceptors, releasing MgADP
and Pi as products.(7, 16) The initial rates of Pi release were measured using the
phosphorylase a/phosphoglucomutase/glucose-6-phosphate dehydrogenase coupled assay system to determine
the 𝑘𝑘cat and 𝑘𝑘cat /𝐾𝐾m MgATP values for the HCO3–-dependent ATPase reaction. While this assay system had
proven to be reliable for the determination of the 𝑘𝑘cat with saturating concentrations of MgATP,
MgATP 𝐾𝐾m values determined using this coupled assay system were at least 2 orders of magnitude higher than
those reported for the R. etli wild-type-catalyzed reaction(17) and those subsequently determined with the
PNP/MESG coupled assay system.(5) The discrepancy is most likely due to the ability of phosphorylase a to bind
nucleotides, thereby reducing the overall concentrations of MgATP in solution.(18) Consequently, while
the 𝑘𝑘cat /𝐾𝐾m,MgATP values in Tables 6 and 7 cannot be considered absolute values, the apparent 𝐾𝐾m values for
MgATP determined with this assay system were used to establish the general effects of these mutations relative
to the wild-type enzyme assayed under the same conditions.
Table 6. Activities of the Biotin Carboxylase Domain Mutants for the HCO3–-Dependent ATPase Reactiona
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /𝑲𝑲𝐦𝐦,𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌 % wild-type 𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 (min–1)b
% wild-type 𝑲𝑲𝐦𝐦,𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌 (m
𝑲𝑲𝐦𝐦,𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌
rate
M)
(min–1 mM–1)
wild-type
0.68 ± 0.03
(100)
0.89 ± 0.09
0.76 ± 0.05
(100)
c
E218A
NA
E218Q
0.034 ± 0.002 5
2.8 ± 0.4
0.012 ± 0.009
1.6
d
K245Q
1.0 ± 0.4
150
0.3 ± 0.2
3.06 ± 0.05
400

E305A
0.32 ± 0.01
48
0.82 ± 0.03
0.39 ± 0.02
50
E305Q
0.19 ± 0.02
30
0.98 ± 0.01
0.19 ± 0.08
25
E305D
0.55 ± 0.04
82
0.7 ± 0.1
0.79 ± 0.09
100
R301Q
0.13 ± 0.04
20
0.12 ± 0.02
1.1 ± 0.1
145
e
R301K
0.14 ± 0.03
20
0.053 ± 0.006 2.5 ± 0.5
330
R353K
0.33 ± 0.07
50
0.10 ± 0.01
3.2 ± 0.4
420
R353M
0.58 ± 0.01
85
0.30 ± 0.02
1.9 ± 0.1
250
E305A/K1119Q
0.336 ± 0.007 50
0.068 ± 0.007 4.9 ± 0.5
640
R353M/K1119Q
1.16 ± 0.06
170
0.22 ± 0.03
5.5 ± 0.6
720
a
Reaction conditions: 50 mM Bis-Tris, 25 mM tricine, 25 mM glycine (pH 7.5), 25 °C, 15 mM HCO3–, 7.5 mM
MgCl2, MgATP (0.09–3.0 mM), 0.25 mM acetyl-CoA.
b
Data fitted to eq 1 unless otherwise indicated.
c
NA = no activity detected.
d
Substrate inhibition with respect to MgATP data fitted to eq 2, Ki = 0.4 ± 0.2 mM.
e
Substrate inhibition, Ki = 4.1 ± 0.4 mM.
Table 7. Activities of the Biotin Carboxylase Domain Mutants for the HCO3–-Dependent ATPase Reaction in the
Presence of Free Biotina
𝑲𝑲𝐦𝐦,𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌 (mM 𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /𝑲𝑲𝐦𝐦,𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 (min–1)b
% wild% wild-type 𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /
–1
–1
𝑲𝑲𝐦𝐦,𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌𝐌
type rate
)
(min mM )
wild-type
0.93 ± 0.04
(100)
1.2 ± 0.1
0.75 ± 0.05
(100)
c
E218A
NA
E218Q
0.015 ± 0.005 2
1.0 ± 0.2
0.015 ± 0.006
2
K245Q
0.032 ± 0.005 3
1.81 ± 0.02
0.018 ± 0.04
2.5
E305A
0.41 ± 0.02
44
0.05 ± 0.01
8.2 ± 0.9
1090
E305Q
0.28 ± 0.03
30
1.7 ± 0.5
0.16 ± 0.01
21
E305D
0.88 ± 0.07
95
0.5 ± 0.1
1.7 ± 0.2
225
R301Q
0.11 ± 0.04
12
0.25 ± 0.03
0.47 ± 0.02
63
R301K
0.23 ± 0.01
25
0.98 ± 0.07
0.234 ± 0.02
31
d
R353K
0.62 ± 0.06
67
0.18 ± 0.03
3.4 ± 0.4
450
R353M
0.481 ± 0.006 52
0.050 ± 0.004
9.5 ± 0.6
1260
E305A/K1119Q
0.41 ± 0.02
45
0.21 ± 0.04
1.9 ± 0.3
250
R353M/K1119Qe 1.29 ± 0.02
140
0.257 ± 0.009
5.01 ± 0.08
670
a
Reaction conditions: 50 mM Bis-Tris, 25 mM tricine, 25 mM glycine (pH 7.5), 25 °C, 15 mM HCO3–, 10 mM biotin,
7.5 mM MgCl2, MgATP (0.09–3.0 mM), 0.25 mM acetyl-CoA.
b
Data fitted to eq 1 unless otherwise indicated.
c
NA = no activity detected.
d
Substrate inhibition with respect to MgATP data fitted to eq 2, Ki = 2.8 ± 0.7 mM.
e
Values determined from global fit of biotin inhibition data to eq 4.
While the E218A mutant had proven to be inactive for any reaction that involved the BC domain, incorporation
of a Gln mutation at Glu218 resulted in a 20-fold decrease in 𝑘𝑘cat and a 60-fold decrease in the 𝑘𝑘cat /
𝐾𝐾m,MgATP relative to the wild-type-catalyzed reaction. The K245Q mutant-catalyzed reaction exhibited a slight
increase in 𝑘𝑘cat as compared to wild-type, but the strong MgATP substrate inhibition (𝐾𝐾i = 0.4 ± 0.2 mM)
made the determination of an accurate 𝑘𝑘cat /𝐾𝐾m value problematic. Nonetheless, it is clear that mutations of
those residues which reside in the MgATP-binding pocket of the BC domain resulted in substantial decreases in
both 𝑘𝑘cat and the apparent 𝑘𝑘cat /𝐾𝐾m MgATP for the HCO3–-dependent ATPase reaction.

The series of Glu305 mutants were moderately active for the HCO3–-dependent ATPase reaction (1.2–3.5-fold
decrease in 𝑘𝑘cat ), and there was no significant effect on the apparent 𝐾𝐾m for MgATP. Interestingly, the
E305A/K1119Q mutant exhibited a 40-fold increase in the 𝑘𝑘cat for the ATPase reaction as compared to the
K1119Q-apoenzyme.(5) When compared to the wild-type-catalyzed reaction, the E305A/K1119Q mutant was
significantly slower, but an accompanying 13-fold decrease in the apparent 𝐾𝐾m for MgATP resulted in a 6-fold
increase in the 𝑘𝑘cat /𝐾𝐾m . Mutations of Arg301 and Arg353 mostly resulted in decreases in 𝑘𝑘cat for MgATPhydrolysis and significant increases in 𝑘𝑘cat /𝐾𝐾m as compared to the wild-type enzyme. Surprisingly, the
R353M/K1119Q double mutant showed a nearly 2-fold increase in 𝑘𝑘cat .

While the addition of 10 mM free biotin had little effect on the 𝑘𝑘cat for reactions catalyzed by the RePC BC
domain mutants (Table 7), its presence did alleviate the observed MgATP substrate inhibition for the K245Q and
R301K mutants. Most notable were the effects of free biotin on those mutant enzyme forms whose mutations
were contained within the putative biotinbinding pocket of the BC domain (Figure 1). With the exception of the
E305A, R353M, and R353M/K1119Q mutants, free biotin increased the apparent 𝐾𝐾m,MgATP for the BC domain
mutants, resulting in enzyme-catalyzed reactions with only marginal decreases in 𝑘𝑘cat /𝐾𝐾m compared to the
wild-type enzyme. Significant decreases in the apparent 𝐾𝐾m,MgATP were observed for the E305A- and R353Mcatalyzed reactions in the presence of free biotin, giving rise to an order of magnitude increase in catalytic
efficiency compared to the wild-type-catalyzed reaction with 10 mM biotin. Free biotin also induced MgATP
substrate inhibition (𝐾𝐾i = 2.8 ± 0.7 mM) in the R353K mutant catalyzed reaction. In contrast to the activating
effect free biotin has on the K1119Q-catalyzed HCO3–-dependent ATPase reaction,(5, 7) biotin was determined
to be a linear uncompetitive inhibitor of the R353M/K1119Q-catalyzed reaction with respect to MgATP (𝐾𝐾i =
4.5 ± 0.1 mM, Figure 2). Further, only a minimal effect on the apparent 𝐾𝐾m,MgATP was observed with the
E305A/K1119Q mutant in the presence of 10 mM biotin (Table 7).

Figure 2. Reciprocal plots demonstrating the linear, uncompetitive inhibition with respect to MgATP by free
biotin for the bicarbonate-dependent ATPase reaction catalyzed by the R353M/K1119Q RePC double mutant.
Solid lines indicate the least-squares fits to eq 3 at varying concentrations of MgATP (0.09–3.0 mM) and fixed
concentrations of biotin (0 mM, black; 1 mM, red; 3 mM, blue; 5 mM, green; 7 mM, pink; 10 mM, cyan).
The 𝑘𝑘cat and 𝑘𝑘cat /𝐾𝐾m for the phosphorylation of MgADP using carbamoyl phosphate as the phosphoryl donor
was also determined for all of the BC domain mutants (Table 8). The E218A mutant was not active for the
phosphorylation reaction, while the apparent carbamoyl phosphate substrate inhibition detected in the K245Q
mutant-catalyzed reaction was so strong that, again, reasonable values for 𝑘𝑘cat and 𝑘𝑘cat /𝐾𝐾m for carbamoyl
phosphate could not be determined. The E218Q mutant exhibited the greatest measurable decrease in 𝑘𝑘cat and
an overall 14-fold decrease in the 𝑘𝑘cat /𝐾𝐾m . Similar patterns of reactivity were observed for the E305Q, R301Q,
and R301K mutants which had significant decreases in 𝑘𝑘cat (4–16% of wild-type activities) and 𝑘𝑘cat /𝐾𝐾m (7–10%
that of wild-type RePC). Conversely, the E305D, E305A/K1119Q, and R353K RePC mutants exhibited slightly
increased 𝑘𝑘cat values for MgADP phosphorylation with carbamoyl phosphate as the phosphoryl donor.
Remarkably, the R353M-catalyzed phosphorylation of MgADP was 10-fold faster than the wild-type-catalyzed

phosphorylation reaction, partially accounting for the 30-fold increase in catalytic efficiency. While the 𝑘𝑘cat of
the E305A single mutant catalyzed reaction was only 30% of that of the wild-type rates, an accompanying
decrease in the 𝐾𝐾m for carbamoyl phosphate gave rise to a 𝑘𝑘cat /𝐾𝐾m value similar to that observed for MgADP
phosphorylation with the E305A/K1119Q double mutant. The R353M/K1119Q mutant displayed an
unexpectedly low activity for the phosphorylation reaction when compared to the 𝑘𝑘cat determined for the
R353M single RePC mutant (1% of 𝑘𝑘cat ). As with the E305A/K1119Q RePC mutant, a considerable decrease in
the 𝐾𝐾m for carbamoyl phosphate with the R353M/K1119Q mutant catalyzed reaction resulted in 𝑘𝑘cat /𝐾𝐾m values
that were almost 90% of that determined for wild-type RePC.
Table 8. Activities of the Biotin Carboxylase Domain Mutants for the ADP Phosphorylation Reaction Using
Carbamoyl Phosphate as the Phosphoryl Donora
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 (min–1)b
% wild% wild-type 𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /
𝑲𝑲𝐦𝐦,𝐂𝐂𝐂𝐂 c (m
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /𝑲𝑲𝐦𝐦,𝐂𝐂𝐂𝐂 (min–
1
–1
type rate M)
𝑲𝑲𝐦𝐦,𝐂𝐂𝐂𝐂
mM )
wild-type
2.4 ± 0.1
(100)
2.6 ± 0.5
0.93 ± 0.02
(100)
d
E218A
NA
E218Q
0.10 ± 0.01
4
1.5 ± 0.5
0.067 ± 0.006
7
e
K245Q
E305A
0.79 ± 0.02
33
0.31 ± 0.02 2.6 ± 0.1
280
E305Q
0.255 ± 0.006 10
3.2 ± 0.2
0.079 ± 0.002
8
E305D
5.4 ± 0.1
225
0.35 ± 0.05 16 ± 3
1720
R301Q
0.39 ± 0.06
16
0.89 ± 0.02 0.45 ± 0.02
50
R301K
0.108 ± 0.004 4.5
1.2 ± 0.3
0.092 ± 0.003
10
R353K
3.4 ± 0.1
140
5.3 ± 0.5
0.79 ± 0.05
85
R353M
24.9 ± 0.8
1000
0.9 ± 0.2
28 ± 4
3010
E305A/K1119Q
2.6 ± 0.2
100
1.4 ± 0.1
1.8 ± 0.1
190
R353M/K1119Q
0.30 ± 0.01
12
0.37 ± 0.09 0.8 ± 0.1
86
a
Reaction conditions: 50 mM Bis-Tris, 25 mM tricine, 25 mM glycine (pH 7.5), 25 °C, 7.5 mM MgCl2, 3.5 mM
MgADP, carbamoyl phosphate (1.0–20 mM), 0.25 mM acetyl-CoA.
b
Data fitted to eq 1 unless otherwise indicated.
c
CP = carbamoyl phosphate.
d
NA = no activity detected.
e
Due to the extreme substrate inhibition with respect to carbamoyl phosphate reasonable values could not be
determined.
Acetyl phosphate was discovered to be a suitable substitute for carbamoyl phosphate in the MgADP
phosphorylation reaction catalyzed by wild-type RePC.(5) The 𝑘𝑘cat and 𝑘𝑘cat /𝐾𝐾m for MgADP phosphorylation
using acetyl phosphate as the phosphoryl donor were determined for the RePC mutants where the incorporated
mutations were located near the putative HCO3–/biotin binding site (Table 9). With the exception of the
E305A/K1119Q RePC double mutant, the 𝑘𝑘cat and 𝐾𝐾m values with acetyl phosphate were considerably less than
those determined for carbamoyl phosphate. Even so, the 𝑘𝑘cat /𝐾𝐾m determined for the R353K- and R353Mcatalyzed reactions with acetyl phosphate were comparable to those determined with carbamoyl phosphate,
while the E305A RePC mutant exhibited a nearly 7-fold decrease in 𝑘𝑘cat /𝐾𝐾m with acetyl phosphate as the
phosphoryl donor. In contrast to the previously established activating effects of free biotin on the rate of the
wild-type-catalyzed phosphorylation of MgADP,(5, 7, 19) 10 mM biotin had little effect on the BC domain
mutant-catalyzed phosphorylation, with either acetyl phosphate (Table 9) or carbamoyl phosphate (data not
shown) as the phosphoryl donor.

Table 9. Activities of the Biotin Carboxylase Domain Mutants for the ADP Phosphorylation Reaction Using Acetyl Phosphate as the Phosphoryl Donora
(+) 10 mM
biotin
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /𝑲𝑲𝐦𝐦,𝐀𝐀𝐀𝐀𝐀𝐀
𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 (min–1)b
𝑲𝑲𝐦𝐦,𝐀𝐀𝐀𝐀𝐀𝐀 c (mM) 𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /
% wild𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 (min–1)
𝑲𝑲𝐦𝐦 (mM)
% wild–
–1
–1
𝑲𝑲𝐦𝐦,𝐀𝐀𝐀𝐀𝐀𝐀 (min
type 𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /
type 𝒌𝒌𝐜𝐜𝐜𝐜𝐜𝐜 /
(min mM )
1
mM–1)
𝑲𝑲𝐦𝐦
𝑲𝑲𝐦𝐦,𝐀𝐀𝐀𝐀𝐀𝐀
wild-type
0.58 ± 0.01
0.34 ± 0.02
1.70 ± 0.005
(100)
0.29 ± 0.002
0.14 ± 0.04 2.1 ± 0.2
(100)
E305A
0.189 ± 0.003
0.61 ± 0.05
0.309 ± 0.005 18
0.105 ± 0.001
0.98 ± 0.02 0.107 ± 0.006
5
R353K
0.37 ± 0.03
0.49 ± 0.04
0.75 ± 0.02
44
0.21 ± 0.01
0.43 ± 0.03 0.48 ± 0.02
23
R353M
14.2 ± 0.3
0.48 ± 0.03
30 ± 2
1760
13.7 ± 0.1
0.48 ± 0.02 28.4 ± 0.2
1350
E305A/K1119Q
2.66 ± 0.06
0.8 ± 0.1
3.40 ± 0.05
200
2.90 ± 0.09
0.9 ± 0.1
3.3 ± 0.5
160
R353M/K1119Q
0.55 ± 0.01
1.5 ± 0.2
0.37 ± 0.04
22
0.602 ± 0.003
0.68 ± 0.05 0.85 ± 0.05
40
a
Reaction conditions: 50 mM Bis-Tris, 25 mM tricine, 25 mM glycine (pH 7.5), 25 °C, 7.5 mM MgCl2, 3.5 mM MgADP, acetyl phosphate (0.1–20 mM), 0.25
mM acetyl-CoA.
b
Data fitted to eq 1 unless otherwise indicated.
c
AcP = acetyl phosphate.

Coupling between the Reactions of the Biotin Carboxylase and Carboxyl Transferase
Domains

The extent of coupling between MgATP-cleavage in the BC domain and pyruvate carboxylation in the CT domain
was established by monitoring the initial rates of Pi release and oxaloacetate formation in the presence of
varying concentrations of pyruvate under identical reaction conditions for the wild-type, R353M, and E305Acatalyzed reactions (Figure 3). Plots of the ratio of the initial rates of oxaloacetate formation/initial rates of
Pi release vs pyruvate concentration were hyperbolic for both the wild-type and E305A-catalyzed reactions. The
ratio of 𝑣𝑣OAA formation /𝑣𝑣Pi release approaches the limiting value of 1.08 ± 0.02 for the wild-type-catalyzed
reaction in the presence of saturating acetyl-CoA and free Mg2+, indicating a near stoichiometric coupling
between MgATP-cleavage and oxaloacetate formation at saturating concentrations of pyruvate. While a similar
limiting value of 0.983 ± 0.01 was determined for the E305A-catalyzed reactions, the 𝐾𝐾d determined for
pyruvate (0.031 ± 0.003 mM) was 8-fold lower than that determined for the wild-type-catalyzed reactions (0.25
± 0.003 mM). Unlike in the wild-type- and E305A-catalyzed reactions, the limiting ratio of the 𝑣𝑣OAA formation /
𝑣𝑣Pi release in the R353M-catalyzed reactions was determined to be only 0.83 ± 0.02 (eq 4).

Figure 3. Ratios of the initial rates of oxaloacetate formation to Pi release at varying concentrations of pyruvate
(0.09–5.25 mM) for the wild-type (○), E305A (▲), and R353M (●) mutant RePC-catalyzed reactions. Both the
E305A and wild-type data were fitted to eq 1 while data for the R353M catalyzed reaction were fitted to eq 4.

Discussion
The MgATP-dependent carboxylation of biotin in the BC domain by HCO3– is proposed to occur through the
formation of carboxyphosphate and subsequent carboxylation of the tethered-biotin enolate.(4) The observed
transfer of 18O from HCO3– to phosphate in the forward reaction(20) and ability of PC to catalyze the
phosphorylation of MgADP with carbamoyl phosphate supports the existence of a carboxyphosphate
intermediate. On the basis of this two-step mechanism of biotin carboxylation and their general locations in the
BC domain active site, the catalytic residues selected for the current site-directed mutagenesis study can be
loosely categorized as those responsible for the formation of carboxyphosphate and those responsible for the
formation of carboxybiotin. These residues were determined to be pivotal in MgATP-binding and cleavage
(Glu218 and Lys245), HCO3– deprotonation (Glu305 and Arg301), and biotin enolization (Arg353), and the kinetic
data presented here are consistent with the proposed mechanism (Scheme 2).

Scheme 2. Proposed Catalytic Mechanism of the HCO3–-Dependent MgATP Cleavage and Biotin Carboxylation

Lys245 Is Essential to the Binding and Orientation of MgATP

Part of the conserved catalytic triad (Glu218-Lys245-Glu305) which forms a hydrogen-bonded bridging network
between the MgATP and HCO3–-binding pockets in the BC domain active site (Figure 4A), Lys245 is positioned 3.6
Å from the phosphoryl-oxygen of the γ-phosphate of ATP-γ-S in the RePC holoenzyme structure.(3) While
previous kinetic(21, 22) and isotope effect studies(23) suggested that the Lys245–Cys237 pair was responsible
for biotin enolization and carboxylation, the thiolate of Cys237 is buried away from the active site in RePC and is
not involved in catalysis.(3) The extremely strong MgATP substrate inhibition observed for the HCO3–-dependent
ATPase reaction catalyzed by the RePC K245Q mutant, which results in an apparent 𝑘𝑘cat /𝐾𝐾m greater than wildtype RePC, is indicative of increased amounts of nonproductive substrate binding, possibly due to the presence
of several MgATP molecules in a single BC domain active site. Structural evidence has shown that the EcBC
domain active site can not only accommodate a single MgATP in multiple binding modes(24) but also
accommodate the binding of more than one nucleotide in a single active site.(25)

Figure 4. (A) Hydrogen-bonding interactions of the highly conserved catalytic triad, Glu218-Lys245-Glu305,
HCO3–, and MgATP-γ-S determined from the superposition of EcBC (blue, ref 8) and RePC holoenzyme (yellow,
ref 3). The position of Glu218 in both the RePC and EcBC structures suggest that its main catalytic function is to

position Lys245 and lower the pKa of Glu305. (B) The actual (light green) and modeled (dark green) positions of
tethered biotin in the BC domain active site of the T882A RePC mutant crystal structure (pdb 3WT6) relative to
the positioning of HCO3– in the BC domain active site from EcBC (blue). Hydrogen-bonding interactions between
key residues are indicated by dashed lines.
If the observed substrate inhibition in the K245Q RePC mutant is due to the coordination of multiple nucleotides
in a single BC domain active site, then the presence of 10 mM free biotin is most likely prohibiting the binding of
a second nucleotide, thus eliminating the observed MgATP substrate inhibition without affecting the 𝑘𝑘cat of the
K245Q-catalyzed MgATP hydrolysis. The 27-fold decrease in the 𝑘𝑘cat for MgATP hydrolysis, even in the presence
of free biotin, and significant decreases in 𝑘𝑘cat and 𝑘𝑘cat /𝐾𝐾m,MgATP observed in the K245Q-catalyzed
carboxylation of pyruvate can be attributed to the abolishment of interactions between Lys245 and the γphosphate of MgATP. While a significant amount of the substrate binding energy comes from interactions
between the BC active site and the adenosine-ring of MgATP,(26) interactions between Lys245 and the γphosphate of MgATP would still have substantial contributions to catalysis by ensuring the optimal alignment of
the γ-phosphate for the nucleophilic attack by HCO3–.

Glu305 Is the Proposed Active Site Base Which Deprotonates HCO3–

In the EcBC active site,(8) Glu305 is ideally positioned near the oxygen atom of HCO3– (2.9 Å) to act as the active
site base needed to deprotonate HCO3– and initiate the nucleophilic attack of bicarbonate on the γ-phosphate of
MgATP (Figure 4A). A conservative Glu305 to Asp mutation resulted in slight decreases in the rates of pyruvate
carboxylation, MgATP cleavage, and the full reverse reaction. While differing only in their magnitude, a similar
decrease in 𝑘𝑘cat for the MgATP cleavage and phosphorylation of MgADP with carbamoyl phosphate was
observed with the E305Q mutant. In contrast, drastic decreases in the 𝑘𝑘cat and 𝐾𝐾m,MgATP for pyruvate
carboxylation were observed with the E305A mutant (75-fold decrease in 𝑘𝑘cat , 30-fold decrease in the 𝐾𝐾m for
MgATP). Further, the similar rates of MgATP hydrolysis observed with the E305A single mutant, which contains
tethered biotin, and the E305A/K1119Q-apoenzyme suggest that the rate of the HCO3–-dependent cleavage has
now become partially rate-limiting compared to biotin carboxylation.
In wild-type RePC, incomplete coupling between the HCO3–-dependent ATPase reaction and carboxyl transfer
was observed at pyruvate concentrations less than ∼1.5 mM, indicating that concentrations lower than or near
the determined 𝐾𝐾m for pyruvate (1.1 mM)(7) facilitates MgATP cleavage and the subsequent release of the BC
domain products (MgADP and Pi) to a greater extent than the overall reaction (Figure 3). The structure of the
T882A RePC mutant in the preceding article(9) lends structural evidence to a possible mechanism where the
translocation of the BCCP domain, located on top of the B-subdomain lid of the BC domain, to the CT domain in
the presence of a carboxyl acceptor would stimulate the moderately rate-limiting release of BC domain
products.(27) From a mechanistic perspective, these results suggest that while concentrations of pyruvate below
the 𝐾𝐾m will adequately stimulate the movement of carboxybiotin from the BC domain to the CT
domain,(27) they are not sufficient to saturate the enzyme in the full forward reaction. Thus, the disassociation
of pyruvate prior to carboxylation occurs more often.(28)
It is expected, then, that the extent of coupling between the reactions of the BC and CT domains at
subsaturating concentrations of pyruvate in the E305A-catalyzed reaction would increase since the initial
deprotonation of HCO3– is now partially rate-limiting. In fact, while the rates of both Pi release and oxaloacetate
formation are significantly lower in the RePC E305A mutant, a tighter coupling between the reactions of the
individual domains is observed at considerably lower concentrations of pyruvate (𝐾𝐾a,pyruvate = 0.03 mM) than
in the wild-type enzyme (Figure 3). Invoking a similar mechanistic rationale, the E305A RePC enzyme requires a
lower concentration of pyruvate to fully saturate the CT domain active site for the full forward reaction, most

likely due to the deprotonation of HCO3– in the BC domain becoming more rate-limiting relative to BCCP–
carboxybiotin translocation and carboxyl transfer in the CT domain.
Analysis of the pH profiles of the full forward reaction with wild-type RePC and MgATP as the variable substrate
and of the full reverse reactions with MgADP as the variable substrate(5) revealed a pKa on the acid side in the
V/K profiles that could possibly be assigned to Glu305. In the pyruvate carboxylation reaction, Glu305 must be
ionized to allow for the initial deprotonation of HCO3– while in the reverse reaction, a proton transfer from
Glu305 to the carboxyphosphate intermediate concurrent with the phosphoryl transfer to MgADP would form a
more reasonable leaving group than carbonate. In contrast to the phosphorylation of MgADP by
carboxyphosphate in the full reverse reaction, the partial reverse reaction of the BC domain using either
carbamoyl phosphate or acetyl phosphate as the phosphoryl donor is pH independent since both the carbamate
and acetate formed during the phosphoryl transfer are good leaving groups.(5) This also suggests that the
E305A RePC mutant would catalyze the phosphorylation of MgADP with the non-natural substrates at least as, if
not more, efficiently than the wild-type enzyme. In fact, the 𝑘𝑘cat /𝐾𝐾m for the E305A and the E305A/K1119Q
catalyzed phosphorylation of MgADP with carbamoyl phosphate is nearly 10 and 3 times that of wild-type RePC,
respectively. Interestingly, while acetylphosphate is also predicted to be a better substrate in the E305Asingle
and double mutant-catalyzed reactions, the observed 𝑘𝑘cat /𝐾𝐾m was only 18% of wild-type values.

Glu218 Interacts with Residues in the Catalytic Triad To Facilitate Catalysis

Located nearly 6 Å away from the γ-phosphate of ATP-γ-S in the RePC holoenzyme structure(3) and ∼7 Å from
HCO3– in the EcBC structure,(8) it is difficult to envision how Glu218 can have such a marked effect on catalysis
(Figure 4A). While the possibilty exists that a single point mutation in the active site may affect the overall
structure of the enzyme, sedimentation analysis of the quaternary structure revealed that the E218Q RePC
mutant exists predominately as a tetramer in solution. Analogous to the effects of the K245Q mutation, the
strong MgATP substrate inhibition observed in the RePC E218Q-catalyzed MgATP-cleavage reaction is partially
alleviated by the presence of 10 mM free biotin. Rather than directly assisting in substrate binding, the position
of Glu218 in the highly conserved catalytic triad (Figure 4A) indicates that hydrogen-bonding interactions with
Glu305 and Lys245 are pivotal to catalysis. The close proximity (2.4–2.8 Å) of Glu218 to Glu305 is suggestive of
the presence of a low-barrier hydrogen bond formed between these two residues which would aid in the
deprotonation of HCO3– and the partial stabilization of the carboxyphosphate intermediate. Interactions
between the carboxylate of Glu218 and the ε-amino group of Lys245 (4 Å) would also raise the pKa of Lys245,
thus favoring its protonation at physiological pH. Retaining the positive charge on Lys245 in the forward reaction
would not only allow for the proper alignment of MgATP(24) but also assist the migration of PO43– from the
MgATP-binding region to the biotin/bicarbonate binding pocket.(29)

Arg301 Bridges the HCO3– and Biotin Binding Pockets
Previous kinetic studies of the corresponding R301A mutant in EcBC(30) suggested that Arg301 has no direct
role in MgATP binding. The 𝐾𝐾m,MgATP values determined for the Arg301 RePC mutants were significantly lower
than wild-type values for the HCO3–-dependent ATPase reaction and the accompanying decrease in 𝑘𝑘cat suggests
that either HCO3– deprotonation or carboxyphosphate formation has now become more rate-limiting in the
catalytic reaction. The positioning of Arg301 at the interface of the proposed biotin/bicarbonate/MgATP-binding
regions of the BC domain in RePC(3) and EcBC(8) suggests that Arg301 not only aids in the alignment and
deprotonation of HCO3– in the initial steps of the catalytic mechanism but also may facilitate the formation of
the biotin enolate by bringing PO43– in close proximity to the N1-position of biotin. In conjunction with the
protonated ε-amino group of Lys245, the guanidinium groups of Arg301 and Arg353 are positioned such that a
small positively charged pocket is formed near the N1-position of both free biotin in EcBC(8) and tethered biotin
(modeled in the BC domain active site) in the T882A RePC mutant structure (dark green,
Figure 4B).(9) Disruption of the positively charged binding pocket in EcBC through the introduction of an

equivalent K245Q mutation resulted in an enzyme form that not only catalyzed MgATP-hydrolysis at a slower
rate than the wild-type enzyme but was also incapable of producing carboxybiotin.(22)
A superposition of the EcBC structure complexed with HCO3– and the BC domain of the T882A RePC mutant
disclosed the distance between HCO3– and the N1-position of the tethered biotin in the proposed, catalytically
active conformation to be 3.4 Å (Figure 4B).(9) Interestingly, the location of the electron density of HCO3– in the
recent EcBC structure(8) overlaps with density for HPO32– observed in the previously determined apo-structure
of EcBC,(29) lending structural support to the proposed role of PO43–- as the base responsible for deprotonating
biotin at the N1-position. While interactions with Arg301 are expected to decrease the pKa of PO43– (∼12.7 for
HPO32–), hydrogen-bonding interactions between Arg353 and the ureido-oxygen of the tethered biotin would
also result in a decrease of the pKa of the proton at the N1-position of biotin (pKa 17.4).(31)

Arg353 Aids in Biotin Enolization and Carboxybiotin Synthesis

In the crystal structure of the T882A RePC mutant with tethered biotin modeled in the BC domain active site
(Figure 4B, dark green), Arg353 is ideally positioned to facilitate biotin enolization through the stabilization of
the developing negative charge at the ureido-oxygen located 3.8 Å away. The decrease in 𝑘𝑘cat and
accompanying decrease in 𝐾𝐾m,MgATP and MgATP substrate inhibition observed for the R353M- and R353Kcatalyzed carboxylation of pyruvate and HCO3–-dependent ATPase reaction suggests that there is a partial
uncoupling between MgATP hydrolysis and carboxybiotin formation in the BC domain, but MgATP cleavage is
mostly unaffected.(32) The inability of the R353M RePC mutant to effectively catalyze the carboxylation of biotin
also results in the uncompetitive inhibition of the R353M/K1119Q catalyzed HCO3–-dependent ATPase reaction
by free biotin (Figure 2). Free biotin is proposed to bind to the BC domain after MgATP and HCO3–,(33) inducing
conformational changes in the active site which aid in preventing the release of Pi and MgADP prior to
carboxylation of either free or tethered biotin.(8) Since the R353M/K1119Q mutant cannot effectively
carboxylate free biotin, the BC domain active site remains in a tighter, closed conformation until the random
motions of the B-subdomain allows for the release of MgADP and Pi.(34) While hydrogen-bonding interactions
with Arg353 are proposed to be the dominant stabilizing effect for the anionic-biotin enolate intermediate,
several other residues are in close proximity to the ureido oxygen of the modeled biotin in the T882A RePC
structure which may aid in the formation of the enolate.(9)
The extent of coupling between the overall reaction of the BC domain and carboxyl transfer in the CT domain for
the R353M RePC mutant-catalyzed reactions was determined at varying concentrations of pyruvate (Figure 3).
The limiting ratio of the 𝑣𝑣OAA formation /𝑣𝑣Pi release in the R353M-catalyzed reactions was determined to be ∼0.8,
signifying incomplete coupling between the reactions of the two active sites. Accordingly, at saturating
concentrations of pyruvate there is a 5-fold difference between the partitioning of the HCO3–-dependent ATPase
reaction through the productive catalytic cycle to form oxaloacetate in the CT domain and through the abortive
pathways of the BC domain, resulting in the nonproductive cleavage of MgATP. Undeniably, the rates of
pyruvate carboxylation and MgATP cleavage and inhibition of the R353M mutant by free biotin indicate that
biotin enolization is partially rate-limiting relative to both the movement of the BCCP–carboxybiotin from the BC
domain to the CT domain and the actual carboxyl transfer in the CT domain in this mutant. If the only role of
Arg353 were to promote carboxybiotin formation in the BC domain, then the ratios of oxaloacetate formation
and Pi release would be expected to eventually reach a limiting value of one, similar to that observed for the
E305A RePC mutant. Thus, the uncoupling of the BC and CT domain reactions even with saturating
concentrations of pyruvate and 4-fold increase in the rate of the full reverse reaction catalyzed by the
R353M RePC mutant strongly suggest that carboxybiotin may have less restricted access to the BC domain active
site in this mutant. Further, the 10-fold increase in the rate of MgADP phosphorylation with carbamoyl
phosphate in the R353M-catalyzed reaction is analogous to that previously observed in the T882A RePC mutant-

catalyzed reactions, where the increased amount of biotin occupancy in the BC domain was proposed to result
in accelerated rates of MgADP phosphorylation compared to the wild-type rates.(7)
The T882A RePC mutant structure shows a catalytically inactive, but relevant, conformation of the tetheredbiotin moiety where the N1-position of biotin is removed from the active site (light green, Figure 4B). The
formation of a salt bridge between Arg353 and Glu248, possibly promoted by the presence of MgADP in the
active site, creates a ridge at the opening of the BC domain which may partially preclude carboxybiotin reentry
into the active site. Previous kinetic studies of sheep and chicken liver PC(27, 35) have described the existence of
two different enzyme–carboxybiotin complexes that are relatively stable in the absence of carboxyl acceptors.
Free Mg2+ decreases the rate of the decay of the enzyme–carboxybiotin complex in both sheep and chicken liver
PC (t1/2 at 0 °C in the absence of any substrates is ∼340 min) and is proposed to facilitate the movement of
carboxybiotin to a more stable position near the BC domain active site. On the basis of the increased relative
stability of the second enzyme–carboxybiotin complex and small accompanying conformational change upon its
formation, it was proposed that carboxybiotin is expelled from the interior of the BC domain active site and
positioned in the vicinity of the active site where the premature decarboxylation of carboxybiotin is less likely to
occur.(27, 35) In fact, the T882ARePC mutant structure may be representative of these two possible positions of
the tethered carboxybiotin, one directly threaded into the BC active site (dark green, Figure 4B) and the second
adjacent to the active site (light green, Figure 4B). Preventing carboxybiotin from returning to the BC domain
prior to the binding of a carboxyl acceptor in the CT domain is one way in which the enzyme reduces the amount
of nonproductive MgATP cleavage. In this way, Arg353 is not only important to the catalytic mechanism of the
BC domain but also key in coordinating the activity between the two spatially distinct active sites.
An attractive alternative to the mechanism by which RePC couples the formation of carboxybiotin in the BC
domain to carboxyl transfer in the CT domain would require the initial coordination of pyruvate to the CT
domain as the driving force for the MgATP-cleavage/biotin carboxylation reaction in the BC domain. While this
mechanism would theoretically abate some nonproductive cleavage of MgATP in that carboxylation of biotin
would only occur when the second substrate is poised in the active site, the particularly rapid decay of the
isolated (sheep kidney) enzyme–carboxybiotin complex in the presence of competitive inhibitors of pyruvate
indicates that biotin carboxylation occurs prior to the coordination of any CT domain active site substrates or
substrate analogues.(27) While the nonproductive cleavage of MgATP to form carboxybiotin when pyruvate
concentrations are less than saturating is an inefficient utilization of ATP, several bacteria species,
including Zymomonas mobilus(36) and Lactococcus cremoris,(37) have been shown to consume ATP in a futile
cycle that is not directly related to cell growth or viability when concentrations of various metabolites are
limited. Given that Rhizobium etli contains phosphoenolpyruvate carboxylase and an α4 PC, both of which are
allosterically regulated by acetyl-CoA,(38) the consequences of the ineffective use of ATP at low concentrations
of pyruvate by RePC is most likely mediated by a several complex regulatory mechanisms. For example, the
formation of the distinct salt bridge between Arg353 and Glu248, hindering the return of carboxybiotin to the
BC domain active site, does increase the coupling between the reactions of the two domains (Figure 3) despite
the inherent level of enzyme inefficiency at low concentrations of pyruvate.
In summary, this detailed structure-driven site directed mutagenesis study offers convincing evidence
supporting the proposed catalytic functions of several highly conserved residues in the BC domain of RePC. The
proposed catalytic mechanism for biotin carboxylation is initiated through the deprotonation of HCO3– by the
active site general base, Glu305, during a concerted nucleophilic attack by bicarbonate on the γ-phosphate of
MgATP, resulting in the formation of a trianionic carboxyphosphate intermediate (Scheme 2). Hydrogen-bonding
interactions within the Lys245-Glu218-Glu305 catalytic triad increase the pKa of Glu305, facilitating the
deprotonation of HCO3–, and stabilize Lys245 in an active conformation, allowing for the formation of key
electrostatic interactions between Lys245 and the γ-phosphate of MgATP. Once formed, the carboxyphosphate

intermediate will reversibly decompose in the active site to CO2 and PO43–. Guided by interactions with Lys245
and Arg301, PO43– migrates toward the tethered biotin in the BC domain active site and deprotonates biotin at
the N1-position. The developing negative charge at the ureido oxygen is partially stabilized by Arg353, thus
promoting the formation of the nucleophilic biotin enolate. Addition of CO2 at N1-position of the biotin enolate
produces carboxybiotin which is rapidly excluded from the active site of the BC domain via the formation of a
discrete salt bridge between Arg353 and Glu248. The newly formed carboxybiotin remains in the vicinity of the
BC domain active site, protected from spontaneous decarboxylation, until the binding of pyruvate, or similar
carboxyl acceptor, in the CT domain active site prompts the translocation of the BCCP–carboxybiotin to the CT
domain.
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Abbreviations
PC
BC
CT
BCCP
ATP
ADP
acetyl-CoA
RePC
hPC
SaPC
BirA
IPTG
NADH
acetyl-CoA
NADP+
Pi
PNP
MESG

pyruvate carboxylase
biotin carboxylase
carboxyl transferase
biotin carboxyl carrier protein
adenosine triphosphate
adenosine diphosphate
acetyl-Coenzyme A
Rhizobium etli PC
human PC
Staphylococcus aureus PC
biotin protein ligase
isopropyl-β-d-thiogalactopyranoside
nicotinamide adenine dinucleotide
acetyl-coenzyme A
nicotinamide adenine dinucleotide phosphate
inorganic phosphate
purine nucleoside phosphorylase
2-amino-6-mercapto-7-methylpurine riboside.

All residues are numbered according to their position in R. etli pyruvate carboxylase, including those mutations
in E. coli biotin carboxylase.
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